Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. - Wikidata - wikimedia - TriplyDB

Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.

Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.

http://www.wikidata.org/entity/Q43419544

about

Direct-acting antivirals for chronic hepatitis C Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Use of the International Classification of Diseases, 9th revision, coding in identifying chronic hepatitis B virus infection in health system data: implications for national surveillance.Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identification.Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data.Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010 Impact of an Electronic Medical Record-Based System to Promote Human Immunodeficiency Virus/Hepatitis C Virus Screening in Public Hospital Primary Care Clinics Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City.Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.Clinical characteristics and current management of hepatitis B and C in China.National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States.Direct-acting antivirals for chronic hepatitis C.Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007 Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system.Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison.Factors Associated with Hepatitis C Knowledge Before and After an Educational Intervention among Vietnamese Americans A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study.Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir.Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).Early Identification and Linkage to Care for People with Chronic HBV and HCV Infection: The HepTLC Initiative.Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014.High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013.Profound jaundice in a patient with acute hepatitis C.A Canadian screening program for hepatitis C: is now the time?Hepatitis C screening trends in a large integrated health system.Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma Chronic hepatitis B and C infection in the United States: a review of current guidelines, disease burden and cost effectiveness of screening.Implementation of Birth-Cohort Testing for Hepatitis C Virus.Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis.Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013.Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records.Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers.Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors.Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department.

P2860

Q24185977-2C540D93-3066-4318-9716-DA067F52E7EF Q26776408-AA68B05E-BA2E-4164-873E-E8849057CD0B Q28545237-343B6162-CAC4-4764-9965-815988559541 Q30391932-6E7B1673-1613-41C1-A64A-8AB60E297763 Q30596772-3A20BAF3-C12E-4E9C-9F5A-15DFA41C7039 Q30836832-5DEDF9BE-374A-428C-8A11-F009E1ECB5C7 Q30861975-C0400CA8-6A95-415D-84F7-59FFFF4B40B6 Q33590896-AFE5ECEE-70CC-49B1-9C28-D44AFAA91225 Q33696050-A04F04F4-AC94-40DC-AA2F-5562295E7AE7 Q33745336-2E06D6D3-E499-4D98-8308-8F70B0998D98 Q33753902-964535E2-909F-4742-9B5B-243CB5F6D04E Q34077806-AE0161F5-66FB-49F4-AA79-AF7EBDAD6BA3 Q34107531-AEDAB50F-1586-40CD-BB7D-5EE485E64048 Q34303075-3FF37109-6556-439D-893C-4F3D9291D1DA Q34354269-554CCD48-2752-47C1-B531-922864A16FC5 Q34557595-E46F3C9B-32C9-4CDD-9A59-76793DF38EF4 Q34675189-7E5E4A4A-4B19-4CF9-9476-D4FB20813EE6 Q35543361-85D9FDF2-200F-419E-9EFC-A5669CF6539F Q36035889-71113D7F-6926-4EAD-A6CC-2E56775B044A Q36104175-E082B3C3-F9DE-461F-B316-05EA0DC23DAE Q36127059-960FC9F5-3248-4D3C-B30E-D5407AB68CCF Q36239160-551AA4E1-E207-4427-B568-4D5B45ABB1BE Q36340733-9F98E4D1-B0C9-4B20-911D-ABA76D56AB2A Q36663835-88CD4733-F128-4E2B-90B6-EA2D0361C98C Q36840571-883EA4EF-B4C7-48BE-AE0E-259CC60BDE23 Q36858833-8AB66871-D4C3-4778-BAFE-6C7077B42D3A Q36858838-5973EDA4-B103-4B33-84B9-79DD084AC19F Q36858890-381CCC29-EC73-44A4-A6B1-E933B6DE6613 Q37223719-778D7141-D933-4AEA-A53E-837C1D56AE81 Q37229672-27A8F975-6B05-4542-8314-08DB0A025498 Q37722406-C375FBF6-952D-438B-9ED1-826531382680 Q38106951-48AE9EDE-8AD7-4AD0-B041-CB08654685B0 Q38797618-B91E83AD-858F-471E-91B5-CBE3F12A2EBA Q38833915-08267816-9715-42E3-B3B5-F675254A52D0 Q38846376-76340BB0-0E73-4BAC-BF74-89FA12B6AF82 Q39377075-B0CD6F06-AE8D-4B9D-84CA-46F2B17D1C30 Q39458281-FDDDEAD4-4A9A-4574-BD32-43BDB86CD45D Q40104694-85D49063-3C21-4CE2-A6C8-42E4B5C61C54 Q40169020-8BD42CDC-819C-4F71-8DE9-8D9DBA9AFAD7 Q40219302-4CFEAD4F-B46D-4E86-B546-CD954E5CCB04

P2860

Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence.

http://www.wikidata.org/entity/Q43419544

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Hepatitis B and C virus infect ...... ting and infection prevalence.

@en

Hepatitis B and C virus infect ...... ting and infection prevalence.

@nl

type

label

Hepatitis B and C virus infect ...... ting and infection prevalence.

@en

Hepatitis B and C virus infect ...... ting and infection prevalence.

@nl

prefLabel

Hepatitis B and C virus infect ...... ting and infection prevalence.

@en

Hepatitis B and C virus infect ...... ting and infection prevalence.

@nl

P1433

Q43419544-F3E151FE-5DEC-4BA8-BE47-80F144A759E0

P1476

Q43419544-52621A0C-D52B-4CC7-A70D-FD790C42E8EA

P2093

Q43419544-31F9514B-375A-49E0-919A-DA29C018CB02

Q43419544-3999BC40-F910-4796-A7AF-2F86CB492590

Q43419544-406D4211-C76E-47B0-9C7C-4A88B55861D7

Q43419544-4B6BCA8A-864A-4E05-A608-1408892474CC

Q43419544-5063F676-29B2-4F12-AB10-0D8507BB6C40

Q43419544-56BF2E25-A18D-49CB-AD49-5B38B04F2218

Q43419544-747EE370-880D-47A0-A47F-B2A4512C2E24

Q43419544-767C1947-6ADD-4AD3-8A84-F7060E79FEED

Q43419544-7A5D3FC4-2E2A-483E-BB42-24CED92D1AEE

Q43419544-B55934E1-6364-43B9-87ED-422D326A5088

P2860

Q43419544-095E1E82-F90B-4D0E-9142-29B336D885C2

Q43419544-20BBC5BB-186E-4EA5-BC73-BF4B39A16CE2

Q43419544-2351D428-013C-4125-82C5-17F8CC728D3C

Q43419544-65DDD0FD-1E7C-4195-A6D2-81A4BF6F23AC

Q43419544-8DB61899-58B8-4756-B2DC-138B1C5D204B

Q43419544-8FA40D4D-D8F2-4C94-9600-B859CB191259

Q43419544-922B2DD6-7447-4834-920A-14FA69BFAF48

Q43419544-97B6A23E-116E-4B37-9DCD-D5EF4CAA259D

Q43419544-9AFDE9E1-65DA-4D2C-96DA-FD5D11AF5337

Q43419544-A8FE58BB-6F34-49EF-A8FB-8CAA6588396B

P304

Q43419544-E3972F32-0D07-4595-B236-B2CF98D0F4C3

P31

Q43419544-168FAB1C-1E57-4C1C-AD5D-7539DE456B58

P356

Q43419544-BBE3E3FE-4A79-4583-AB19-002E4E11B168

P407

Q43419544-68865A52-4A5B-47FB-A6BB-C17010E8EB2A

P433

Q43419544-FC75926C-6EBE-439C-A99F-F93DC2FC9041

P478

Q43419544-2440DE70-DA7F-4A6B-9287-AD70BD1C4B09

P50

Q43419544-DF51F28F-48ED-4318-8D54-C0F516B343FE

P577

Q43419544-5C45C1F6-F6AF-4765-87CB-F6293461BF58

P5875

Q43419544-3132B483-0440-437D-A457-6858FF13873E

P698

Q43419544-FCF3B2DE-9AB0-4B00-946A-20D7A49CC8FE

P932

Q43419544-6448F45F-AB48-40F2-95B4-73E7C66CA8B4

P356

P1433

Clinical Infectious Diseases

P1476

Hepatitis B and C virus infect ...... ting and infection prevalence.

@en

P2093

Chronic Hepatitis Cohort Study Investigators

http://www.w3.org/2001/XMLSchema#string

Cynthia Nakasato

http://www.w3.org/2001/XMLSchema#string

David R Nerenz

http://www.w3.org/2001/XMLSchema#string

Emily M Henkle

http://www.w3.org/2001/XMLSchema#string

Eyasu H Teshale

http://www.w3.org/2001/XMLSchema#string

Joseph A Boscarino

http://www.w3.org/2001/XMLSchema#string

Loralee Rupp

http://www.w3.org/2001/XMLSchema#string

Maxine M Denniston

http://www.w3.org/2001/XMLSchema#string

Mei Lu

http://www.w3.org/2001/XMLSchema#string

Philip R Spradling

http://www.w3.org/2001/XMLSchema#string

P2860

Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California

Diagnosis, management, and treatment of hepatitis C: an update

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.

Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.

Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity.

Hepatitis B virus infection: epidemiology and vaccination.

Surveillance programs for chronic viral hepatitis in three health departments

Rate and predictors of treatment prescription for hepatitis C.

Testing for hepatitis C virus infection should be routine for persons at increased risk for infection.

P304

1047-1055

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIS616

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Anne C. Moorman

P577

2012-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230638839

http://www.w3.org/2001/XMLSchema#string

P698

22875876

http://www.w3.org/2001/XMLSchema#string

P932

6429561

http://www.w3.org/2001/XMLSchema#string